Identity
- Trade Name
- HMS-5000-COMPACT-QUADRO FDA UDI
- Generic Name
- Hyperbaric chamber, stationary FDA UDI
- Device Name
- The HMS-5000-12 is a Class A, pressure vessel for human occupancy (PVHO) that is designed in a rectangular geometry. It has two (2) compartments and is capable of administering hyperbaric oxygen therapy treatments up to twelve (12) patients simultaneously. It is one of the models contained within the HMS 5000 Rectangular Multiplace Hyperbaric Chamber System Product Family. It is comprised of a multiplace hyperbaric chamber with a number of major subsystems that are interconnected to form a complete system, which includes an operation control system that uses computer control technology. Pressures up to 6ATA (~73.5psi). The HMS-5000 multiplace hyperbaric chamber is designed, fabricated, and tested in compliance with the following FDA consensus standards: American Society of Mechanical Engineers / Pressure Vessel for Human Occupancy (ASME/PVHO-1) and the National Fire Protection Agency (NFPA) 99, Health Care Facilities. FDA UDI
- Model / Reference
- HMS-5000-12 FDA UDI
- Description
- The HMS-5000-12 is a Class A, pressure vessel for human occupancy (PVHO) that is designed in a rectangular geometry. It has two (2) compartments and is capable of administering hyperbaric oxygen therapy treatments up to twelve (12) patients simultaneously. It is one of the models contained within the HMS 5000 Rectangular Multiplace Hyperbaric Chamber System Product Family. It is comprised of a multiplace hyperbaric chamber with a number of major subsystems that are interconnected to form a complete system, which includes an operation control system that uses computer control technology. Pressures up to 6ATA (~73.5psi). The HMS-5000 multiplace hyperbaric chamber is designed, fabricated, and tested in compliance with the following FDA consensus standards: American Society of Mechanical Engineers / Pressure Vessel for Human Occupancy (ASME/PVHO-1) and the National Fire Protection Agency (NFPA) 99, Health Care Facilities. FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00860006478902 FDA UDI
- 510(k) Number
- K152223 FDA UDI
- FDA Product Code
- CBF FDA UDI
- GMDN Term
- Hyperbaric chamber, stationary FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 868.5470 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
Yes
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
Yes
FDA UDI
Expiration Date
No
FDA UDI
Manufacturing Date
Yes
FDA UDI
Category: Hyperbaric chamber, stationary
Hms-5000-Compact-Quadro by Hyperbaric Modular Systems, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Hyperbaric chamber, stationary.
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
- Perry Sigma Monoplace — Perry Baromedical Corporation · Class II
- Sechrist Industries, Inc. — Sechrist Industries Inc · Class II
Cleared under the same submission
K152223 also covers:
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Hyperbaric Modular Systems, Inc.
Sources (1)
- FDA UDI 9f85450e-f0da-473a-94e3-209272c02d56 34 fields · synced May 30, 2026